• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗在变时性功能不全和慢性心力衰竭患者中的应用。

Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure.

机构信息

Division of Cardiology, Department of Medicine, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USA.

出版信息

Europace. 2011 Oct;13(10):1459-63. doi: 10.1093/europace/eur127. Epub 2011 May 7.

DOI:10.1093/europace/eur127
PMID:21551475
Abstract

AIMS

Chronotropic incompetence (CI) is a common finding in patients with advanced chronic heart failure (CHF) and is associated with a worse functional capacity. Whether rate responsive pacing with cardiac resynchronization therapy (CRT) would acutely improve exercise performance in patients with advanced CHF and severe CI (<70% age-predicted maximum heart rate) is unknown.

METHODS AND RESULTS

Patients (n = 13) with CHF, a CRT device, and severe CI were randomized in a double-blind crossover pilot study to either DDD (control) or DDDR (rate responsive) pacing. Six minutes walk test (6MWT) distance, oxygen consumption at anaerobic threshold (VO(2) @ AT), and maximal oxygen consumption (VO(2) max) were measured. One week later, testing was repeated in the alternate pacing mode. Rate responsive pacing commenced with standard settings in only 9 of 13 (69%) patients. In these 9 subjects, 6MWT distance improved acutely from 358.5 ± 40.7 to 376.8 ± 24.5 m with DDDR pacing (P< 0.05). VO(2) max did not improve with DDDR pacing (14.0 ± 3.2 mL/kg/min) compared with DDD pacing (13.9 ± 3.0 mL/kg/min; P= 0.69). VO(2) @ AT tended towards improvement with DDDR pacing (10.8 ± 2.9 mL/kg/min) compared with DDD pacing (9.6 ± 1.8 mL/kg/min; P= 0.29). There was a linear relationship between the increase in heart rate at minute 3 during rate responsive pacing and improvement in VO(2) @ AT (r = 0.83, P< 0.05).

CONCLUSION

When rate responsive pacing using a CRT device is achieved in patients with advanced CHF and severe CI, parameters of aerobic exercise performance improve acutely. Routine exercise testing to ensure successful restoration of heart rate response may be beneficial to optimize CRT settings in this patient population.

摘要

目的

变时性功能不全(CI)是晚期慢性心力衰竭(CHF)患者的常见表现,与较差的功能能力相关。使用心脏再同步治疗(CRT)的频率适应性起搏是否会急性改善晚期 CHF 伴严重 CI(<70%年龄预测最大心率)患者的运动表现尚不清楚。

方法和结果

本双盲交叉先导研究纳入了 13 名 CHF 患者、携带 CRT 设备且 CI 严重的患者,随机分为双腔(DDD,对照组)或双腔(DDDR,频率适应性)起搏。测量 6 分钟步行测试(6MWT)距离、无氧阈时的耗氧量(VO2@AT)和最大耗氧量(VO2max)。一周后,在交替起搏模式下重复测试。仅 13 例(69%)患者中的 9 例可起始标准设置的频率适应性起搏。在这 9 例患者中,DDDR 起搏时 6MWT 距离从 358.5 ± 40.7 米显著改善至 376.8 ± 24.5 米(P<0.05)。与 DDD 起搏时相比,DDDR 起搏时 VO2max 并未改善(14.0 ± 3.2 毫升/公斤/分钟)(13.9 ± 3.0 毫升/公斤/分钟;P=0.69)。与 DDD 起搏时相比,DDDR 起搏时 VO2@AT 呈改善趋势(10.8 ± 2.9 毫升/公斤/分钟)(9.6 ± 1.8 毫升/公斤/分钟;P=0.29)。在频率适应性起搏的第 3 分钟时心率的增加与 VO2@AT 的改善呈线性关系(r=0.83,P<0.05)。

结论

在晚期 CHF 伴严重 CI 患者中使用 CRT 设备实现频率适应性起搏时,有氧运动表现的参数会急性改善。常规运动测试以确保成功恢复心率反应可能有益于优化该患者人群的 CRT 设置。

相似文献

1
Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure.心脏再同步治疗在变时性功能不全和慢性心力衰竭患者中的应用。
Europace. 2011 Oct;13(10):1459-63. doi: 10.1093/europace/eur127. Epub 2011 May 7.
2
[An intrapatient comparison of adaptation to aerobic and anaerobic exertion during 3 types of physiological cardiac stimulation in chronotropic failure of the sinus node: DDD, VVIR and DDDR].[窦房结变时性功能不全患者在3种生理性心脏刺激(DDD、VVIR和DDDR)过程中对有氧和无氧运动适应情况的自身对照研究]
Cardiologia. 1997 Jan;42(1):51-7.
3
[DDD versus DDDR pacemaker stimulation: comparison of cardiopulmonary performance, incidence of atrial arrhythmias and quality of life].[DDD与DDDR起搏器刺激:心肺功能、房性心律失常发生率及生活质量的比较]
Z Kardiol. 1996 Apr;85(4):226-36.
4
Impact of cardiac resynchronisation therapy on adaptation of circulatory and respiratory systems to exercise assessed by cardiopulmonary exercise test in patients with chronic heart failure.慢性心力衰竭患者中,通过心肺运动试验评估心脏再同步治疗对循环和呼吸系统运动适应性的影响。
Kardiol Pol. 2008 Apr;66(4):406-12; discussion 413-4.
5
The incremental benefit of rate-adaptive pacing on exercise performance during cardiac resynchronization therapy.心脏再同步治疗期间频率适应性起搏对运动能力的增量效益。
J Am Coll Cardiol. 2005 Dec 20;46(12):2292-7. doi: 10.1016/j.jacc.2005.02.097.
6
Optimal Cardiac Resynchronization Therapy Pacing Rate in Non-Ischemic Heart Failure Patients: A Randomized Crossover Pilot Trial.非缺血性心力衰竭患者的最佳心脏再同步治疗起搏频率:一项随机交叉试点试验。
PLoS One. 2015 Sep 18;10(9):e0138124. doi: 10.1371/journal.pone.0138124. eCollection 2015.
7
Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds.左心室与同时双心室起搏治疗心力衰竭伴 QRS 波群≥120 毫秒患者的比较。
Circulation. 2011 Dec 20;124(25):2874-81. doi: 10.1161/CIRCULATIONAHA.111.032904. Epub 2011 Nov 21.
8
A novel algorithm for individualized cardiac resynchronization therapy: rationale and design of the adaptive cardiac resynchronization therapy trial.一种新的个体化心脏再同步治疗算法:适应性心脏再同步治疗试验的原理和设计。
Am Heart J. 2012 May;163(5):747-752.e1. doi: 10.1016/j.ahj.2012.02.007.
9
A mechanistic investigation into how long-term resynchronization therapy confers ongoing cardiac functional benefits and improved exercise capacity.一项关于长期心脏再同步治疗如何持续带来心脏功能益处和提高运动能力的机制研究。
Am J Cardiol. 2009 Mar 1;103(5):701-8. doi: 10.1016/j.amjcard.2008.10.041. Epub 2009 Jan 15.
10
Importance of heart rate during exercise for response to cardiac resynchronization therapy.运动期间心率对心脏再同步治疗反应的重要性。
J Cardiovasc Electrophysiol. 2009 Jul;20(7):773-80. doi: 10.1111/j.1540-8167.2008.01422.x. Epub 2009 Feb 2.

引用本文的文献

1
Activated rate-response is associated with increased mortality risk in cardiac device carriers with acute heart failure.激活的速率反应与急性心力衰竭的心脏设备携带者的死亡率风险增加有关。
PLoS One. 2024 Apr 18;19(4):e0302321. doi: 10.1371/journal.pone.0302321. eCollection 2024.
2
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition.心房颤动诱发的心动过速性心肌病与心力衰竭:一种未得到充分认识且难以捉摸的病症。
Heart Fail Rev. 2022 Nov;27(6):2119-2135. doi: 10.1007/s10741-022-10221-1. Epub 2022 Mar 23.
3
Rate adaptive pacing in people with chronic heart failure increases peak heart rate but not peak exercise capacity: a systematic review.
慢性心力衰竭患者的心率适应性起搏可增加峰值心率,但不能提高峰值运动能力:系统评价。
Heart Fail Rev. 2023 Jan;28(1):21-34. doi: 10.1007/s10741-022-10217-x. Epub 2022 Feb 9.
4
Impact of closed loop stimulation on prognostic cardiopulmonary variables in patients with chronic heart failure and severe chronotropic incompetence: a pilot, randomized, crossover study.闭环刺激对慢性心力衰竭伴严重变时性功能不全患者预后心肺变量的影响:一项先导、随机、交叉研究。
Europace. 2021 Nov 8;23(11):1777-1786. doi: 10.1093/europace/euab110.
5
Predictors of rate-adaptive pacing in patients implanted with implantable cardioverter-defibrillator and subsequent differential clinical outcomes.植入式心脏复律除颤器患者中频率适应性起搏的预测因素及随后的不同临床结局
J Interv Card Electrophysiol. 2019 Jun;55(1):83-91. doi: 10.1007/s10840-019-00536-9. Epub 2019 Mar 30.
6
Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.充血性心力衰竭合并心房颤动时的房室结导管消融术
J Atr Fibrillation. 2018 Jun 30;11(1):1813. doi: 10.4022/jafib.1813. eCollection 2018 Jun-Jul.
7
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.2015年心脏节律学会/欧洲心律协会/亚太心律协会/拉丁美洲心脏电生理和心脏起搏学会关于植入式心脏复律除颤器最佳程控与测试的专家共识声明
J Arrhythm. 2016 Feb;32(1):1-28. doi: 10.1016/j.joa.2015.12.001. Epub 2016 Feb 1.
8
Optimal Cardiac Resynchronization Therapy Pacing Rate in Non-Ischemic Heart Failure Patients: A Randomized Crossover Pilot Trial.非缺血性心力衰竭患者的最佳心脏再同步治疗起搏频率:一项随机交叉试点试验。
PLoS One. 2015 Sep 18;10(9):e0138124. doi: 10.1371/journal.pone.0138124. eCollection 2015.
9
Chronotropic incompetence in Chagas disease: usefulness of dual sensor pacemaker based on volume minute and accelerometer.恰加斯病中的变时性功能不全:基于每分容量和加速度计的双传感器起搏器的效用。
Rev Bras Cir Cardiovasc. 2015 Jul-Sep;30(3):III-VI. doi: 10.5935/1678-9741.20150011.
10
Cardiac resynchronization therapy update: evolving indications, expanding benefit?心脏再同步治疗的进展:适应证不断演变,获益范围扩大?
Curr Cardiol Rep. 2015 Oct;17(10):90. doi: 10.1007/s11886-015-0641-5.